Ferronova is a medical device company, spun out of Victoria University of Wellington and the University of South Australia, producing an advanced diagnostic system to aid in the diagnosis and treatment of cancer.
Ferronova's mission is to provide solutions for staging solid tumour cancers e.g. breast, prostate, rectal and head and neck.
More than 40% of people will be diagnosed with cancer during their lifetime. Successful cancer treatment relies on accurate staging of how far, and where cancer has spread from a primary tumour. Current diagnostic systems are not able to reliably detect small tumours without invasive surgery. The Ferronova technology addresses this problem.
The lymphatic system is the primary pathway for the spread of most cancers. Ferronova products will be used either as a tracer for MRI scans or in Sentinal Lymph Node Biopsies to identify the spread of cancer and subsequent treatments. The key products, a magnetic probe and smart super paramagnetic iron oxide nanoparticles, are protected by patents.
Ferronova’s system will be marketed by established surgical equipment manufacturers.